There are few available adjuvant/neoadjuvant medicines for treatment of high-risk resectable colorectal cancer. Lack of pipeline agents in this setting presents a good opportunity for development of effective treatments that can improve cure rates for resected patients.
This report contains market size and forecasts of Colorectal Cancer Drugs in global, including the following market information:
Global Colorectal Cancer Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Colorectal Cancer Drugs Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Colorectal Cancer Drugs companies in 2021 (%)
The global Colorectal Cancer Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Vascular Endothelial Growth Factor (VEGF) Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Colorectal Cancer Drugs include AB Science, Amgen, Array BioPharma, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Elli Lilly, Roch and Hutchison MediPharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Colorectal Cancer Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Colorectal Cancer Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Colorectal Cancer Drugs Market Segment Percentages, by Type, 2021 (%)
Vascular Endothelial Growth Factor (VEGF) Inhibitors
Epidermal Growth Factor Receptor (EGFR) Inhibitors
Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
BRAF or MEK Inhibitors
Tyrosine Kinase (TKI) Inhibitors
Immunomodulators
Global Colorectal Cancer Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Colorectal Cancer Drugs Market Segment Percentages, by Application, 2021 (%)
Radiotherapy
Chemotherapy
Global Colorectal Cancer Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Colorectal Cancer Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Colorectal Cancer Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Colorectal Cancer Drugs revenues share in global market, 2021 (%)
Key companies Colorectal Cancer Drugs sales in global market, 2017-2022 (Estimated), (MT)
Key companies Colorectal Cancer Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AB Science
Amgen
Array BioPharma
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Elli Lilly
Roch
Hutchison MediPharma
Merck & Co., Inc.
Mologen
Regeneron
Sanofi
Sumitomo Dainippon
Taiho Pharmaceutical
Vaccinogen